Stress echocardiography compared to exercise ECG for the assessment of acute coronary syndrome
We have read with interest the article by Jeetley et al. 1 on the comparison of the clinical and economic impact of stress echo and exercise ECG for the assessment of acute coronary syndrome in patients with normal troponin. They showed that the cost of the exercise ECG approach was higher, mainly because of the higher performance of angiographies in this group (33 vs. 19%), which matches with the risk stratification achieved by each approach (intermediate or high risk by exercise ECG, 67%; by stress echo, 23%). In spite of this higher number of angiographies in the exercise ECG group, outcome was similar and revascularization procedures were the same (15 vs. 13, data from Figure 3 ). One might suspect that a significant number of angiographies in the exercise ECG intermediate risk patients did not translate into revascularization procedures. We have performed a similar study in patients after acute myocardial infarction. 2 In our study ischemia was more frequently detected by exercise echo than by exercise ECG (59 vs. 27%, P , 0.001) and therefore the number of angiographies and revascularization procedures were higher in the former group (59 vs. 32 angiographies, P , 0.01 and 46 vs. 19 revascularizations, P , 0.001). The percentage of re-admissions for unstable angina, heart failure, and myocardial infarction after a follow-up of 4.5 + 1.8 years was the same. There were 17 hard cardiac events (non-fatal myocardial infarction or cardiovascular death) in the exercise ECG strategy and 19 in the exercise echo strategy (21 vs. 23%). Thus, the performance of angiographies particularly after exercise ECG likely reflects different post-test referral patterns among centres. A more conservative referral pattern for the exercise ECG group in the study by Jeetley et al. (i.e. only angiography in the high risk group) would likely equal the number of angiographies within groups (and the cost). If this approach would translate into similar outcome deserve further studies. Stress echocardiography compared to exercise ECG for the assessment of acute coronary syndrome: reply
We thank Drs Peteiro and Bouzas for their interest in our analysis of economic impact of stress echocardiography (SE). 1 Although it is true that the number of patients undergoing coronary angiography and indeed other tests for the detection of CAD (and hence the cost) was greater in the exercise ECG (ExECG) arm compared with that of the stress echocardiography arm, it should be noted that this was because ExECG resulted in as much as 39% of the patients being classified as intermediate risk compared with only 3% in the SE group. As a result, the majority of patients in this group in the ExECG arm underwent further investigation. On the other hand, ExECG classified more patients as high risk compared with SE, but revascularization was more commonly performed in the latter group, reflecting the fact that SE was more accurate in identifying flow-limiting CAD than ExECG.
2 This is also reflected in more patients after ExECG demonstrating normal coronary angiography compared with those following SE.
The study quoted by the authors that showed an apparent variance from our study consists of an entirely different population, i.e. they are all patients with established acute myocardial infarction with a high prevalence of flow-limiting CAD. 3 Hence, it is not surprising that SE, which is a more sensitive test than exercise ECG for the detection of ischemia, will be more often positive than exercise ECG in this group of patients. Hence, these patients are more likely to undergo revascularization. In either scenario, SE is likely to be more cost-effective. Because of its significant superior specificity compared with ExECG, SE will be able to identify correctly the low-risk group in a lowintermediate risk population like our study demonstrated and because of its superior sensitivity, SE will correctly identify highrisk group in a population which is intermediate-high risk such as those studied by Peteiro et al. 3 However, one must remember that the effectiveness of the test should take into account the life lost if flow-limiting CAD is missed. One study that took this into account did demonstrate that SE is more cost-effective than ExECG, albeit, in a chronic setting. 4 
